Flagship Ventures Fund IV, L.P. Insider Profile
4 Followers
Flagship Ventures Fund IV, L.P., Ten Percent Owner at Carisma Therapeutics, holds 282.01K shares in Carisma Therapeutics (Ticker: CARM), holds 2.81M shares in Editas Medicine (Ticker: EDIT). Most recently, Flagship Ventures Fund IV, L.P. Sold ― shares of Carisma Therapeutics on Sep 26, 2016 for an estimated value of $1.40M.
Flagship Ventures Fund IV, L.P.'s Trading History
You May Also Like
Flagship Ventures Fund IV, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Flagship Ventures Fund IV, L.P.?
The percentage of profitable transactions made by Flagship Ventures Fund IV, L.P. is 100%.
What is the average return per transaction made by Flagship Ventures Fund IV, L.P.?
The average return per transaction made by Flagship Ventures Fund IV, L.P. is 56.60%.
What stocks does Flagship Ventures Fund IV, L.P. hold?
Flagship Ventures Fund IV, L.P. holds: CARM, EDIT stocks.
What was Flagship Ventures Fund IV, L.P.’s latest transaction?
Flagship Ventures Fund IV, L.P.’s latest transaction was an Informative Sell of $1.40M.
What was Flagship Ventures Fund IV, L.P.'s most profitable transaction?
Flagship Ventures Fund IV, L.P.’s most profitable transaction was an Informative Sell of CARM stock on September 16, 2016. The return on the trade was 63.50%.
What is Flagship Ventures Fund IV, L.P.'s role in Carisma Therapeutics?
Flagship Ventures Fund IV, L.P.'s role in Carisma Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
